Risk of Discontinuation of the Company’s In-House Research and Development Program Materializes
First written in FY2024. 3 of 3 entries say "Materialised", first in FY2024. Latest entry: 2026-05-14.
PRISM BioLab moved to the "Worse" side of this theme in 2024, 1 year before the typical company in this theme (2025).
The whole theme swung hardest in 2026: 14 of 29 companies on the "Worse" side.
5 other companies' latest entry also says "Materialised".
- 2026-05-14MaterialisedEarnings
「One program at the “hit compound discovery” stage was discontinued because it did not meet the criteria for hit compound qualification.」
The discontinuation of a hit compound discovery program actually occurred during the current interim period. - FY2025MaterialisedAnnual report
「During the fiscal year, 1 program in the "hit compound discovery" stage that had been underway was discontinued because it failed to reach the planned progress.」
The company's hit compound discovery program failed to reach the planned progress, and discontinuation again actually occurred. - FY2024MaterialisedAnnual report
「A program launched in the previous fiscal year had identified hit compounds and was being advanced toward lead compounds, but it was discontinued because it failed to achieve the target results within the period.」
It was reported that a program was actually discontinued during the fiscal year after failing to achieve its targets.